1. Home
  2. XLO vs BOF Comparison

XLO vs BOF Comparison

Compare XLO & BOF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

XLO

Xilio Therapeutics Inc.

HOLD

Current Price

$8.47

Market Cap

49.8M

Sector

Health Care

ML Signal

HOLD

Logo BranchOut Food Inc.

BOF

BranchOut Food Inc.

HOLD

Current Price

$3.96

Market Cap

49.6M

ML Signal

HOLD

Company Overview

Basic Information
Metric
XLO
BOF
Founded
2016
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
49.8M
49.6M
IPO Year
2021
2023

Fundamental Metrics

Financial Performance
Metric
XLO
BOF
Price
$8.47
$3.96
Analyst Decision
Buy
Analyst Count
1
0
Target Price
$28.00
N/A
AVG Volume (30 Days)
41.7K
40.6K
Earning Date
05-14-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
31.33
EPS
N/A
N/A
Revenue
$43,766,000.00
$3,184,018.00
Revenue This Year
N/A
N/A
Revenue Next Year
$168.77
N/A
P/E Ratio
N/A
N/A
Revenue Growth
589.88
258.20
52 Week Low
$0.46
$1.93
52 Week High
$9.89
$5.25

Technical Indicators

Market Signals
Indicator
XLO
BOF
Relative Strength Index (RSI) 43.22 43.62
Support Level $7.47 $2.86
Resistance Level $8.80 $3.96
Average True Range (ATR) 0.35 0.25
MACD -0.12 -0.07
Stochastic Oscillator 15.49 9.18

Price Performance

Historical Comparison
XLO
BOF

About XLO Xilio Therapeutics Inc.

Xilio Therapeutics Inc is a clinical-stage biotechnology company focused on discovering and developing masked immuno-oncology (I-O) therapies to improve outcomes for people living with cancer. Leveraging its clinically validated masking technology and capabilities, the company develops I-O therapies designed to selectively activate within the tumor microenvironment to achieve durable efficacy without the severe side effects associated with systemically active I-O agents. Its integrated biology and protein engineering approach enables the design and development of potent masked biologics that are activated by tumor-specific proteases.

About BOF BranchOut Food Inc.

Branchout Food inc is engaged in the development, marketing, sale, and distribution of plant-based, dehydrated fruit and vegetable snacks and powders. Its products are currently manufactured for the company by contract manufacturers based in South America and North America that produce dehydrated fruit and vegetable products for the company using a new proprietary dehydration technology that it licenses from a third party. The Company's customers are located throughout the United States. Its current primary products are BranchOut Snacks, BranchOut Powders, and BranchOut Industrial Ingredients.

Share on Social Networks: